LOS ANGELES--(BUSINESS WIRE)--Goldberg Law PC announces that it is investigating claims of potential misrepresentations by Avalanche Biotechnologies, Inc. (“Avalanche” or the “Company”) (NASDAQ: AAVL). The investigation focuses on whether the Company and its officers violated securities laws by issuing misleading information to investors. If you purchased Avalanche shares on or before June 15, 2015, and would like more information regarding the investigation, we advise you to contact Michael Go